Who owns Lexicon Pharmaceuticals?

Key details on Lexicon Pharmaceuticals (Ticker: LXRX)

Who owns Lexicon Pharmaceuticals?

Is LXRX a good stock to own? Find out who bought Lexicon Pharmaceuticals, who sold Lexicon Pharmaceuticals (LXRX) stock, and who holds a large position in Lexicon Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Artal Group S.A. 253.37M $407.93M June 30, 2014
FMR 77.07M $133.33M March 31, 2014
Ulys 29.78M $47.95M June 30, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 19.48M $31.55M June 30, 2014
Vanguard 14.62M $23.53M June 30, 2014
NEA Management Company 11.68M $18.80M June 30, 2014
BlackRock Fund Advisors 11.12M $17.91M June 30, 2014
BlackRock Institutional Trust Company, N.A. 7.35M $11.83M June 30, 2014
T. Rowe Price Associates 6.12M $9.86M June 30, 2014
Invus Public Equities Advisors 3.89M $6.85M June 30, 2011
STATE STREET CORPORATION 3.59M $5.78M June 30, 2014
Perceptive Advisors 3.20M $6.97M March 31, 2013
Schroder Investment Management 3.16M $5.08M June 30, 2014
NORTHERN TRUST 2.96M $5.12M March 31, 2014
JPMORGAN CHASE & CO 2.92M $6.57M June 30, 2012
Royce & Associates 2.89M $4.65M June 30, 2014
Jefferies 2.13M $3.80M Dec. 31, 2013
Franklin Resources 2.11M $5.00M Sept. 30, 2013
Geode Capital Management 2.09M $4.53M June 30, 2013
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 2.08M $3.35M June 30, 2014

Who sold Lexicon Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Dec. 31, 2013 2.54M $4.57M